Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
17.56
+0.16 (0.92%)
At close: Jun 12, 2026, 4:00 PM EDT
17.90
+0.34 (1.94%)
After-hours: Jun 12, 2026, 4:16 PM EDT
Forte Biosciences Employees
Forte Biosciences had 22 employees as of March 31, 2026. The number of employees increased by 3 or 15.79% since the number was last reported on December 31, 2025.
Employees
22
Change
3
Growth
15.79%
Revenue / Employee
n/a
Profits / Employee
-$3,447,955
Market Cap
429.09M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 22 | 3 | 15.79% |
| Dec 31, 2025 | 19 | 5 | 35.71% |
| Dec 31, 2024 | 14 | 5 | 55.56% |
| Dec 31, 2023 | 9 | 3 | 50.00% |
| Dec 31, 2022 | 6 | 1 | 20.00% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Ocugen | 116 |
| Adlai Nortye | 109 |
| C4 Therapeutics | 104 |
| Prelude Therapeutics | 79 |
| Rezolute | 68 |
| Prothena Corporation | 67 |
| Contineum Therapeutics | 51 |
FBRX News
- 4 days ago - Forte Biosciences Registration statement: Registration filing - Filings
- 10 days ago - Forte Biosciences Registration statement: Registration filing - Filings
- 4 weeks ago - Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules - Business Wire
- 4 weeks ago - Forte Biosciences reports Q1 EPS ($1.24), consensus ($1.16) - TheFly
- 4 weeks ago - Forte Biosciences, Inc. Announces First Quarter 2026 Results and Provides Update - Business Wire
- 4 weeks ago - Forte Biosciences Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Forte Biosciences Earnings release: Q1 2026 - Filings
- 6 weeks ago - Forte Biosciences Proxy statement: Proxy filing - Filings